Successful neoadjuvant treatment of EGFR exon 19 deletion combined with TP53 mutation in non-small cell lung cancer using aumolertinib after osimertinib-induced myocardial damage:...

por Zhang, Guijuan, Tang, Xiaoyuan, Zhang, Xingping, Qiu, Xingting, Lai, Qingwen, Li, Jie
Publicado 2023